BCK Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-259,809
Closed -$4.09M 113
2022
Q2
$4.09M Hold
259,809
3.17% 10
2022
Q1
$3.95M Buy
259,809
+172,467
+197% +$2.63M 2.37% 10
2021
Q4
$1.34M Buy
+87,342
New +$1.15M 0.9% 31

Other funds holding NPTN

BCK Capital Management's NPTN Position: Q3 2022 in Review

BCK Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 259,809 shares — an estimated $4.09M sold.

BCK Capital Management first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $4.09M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • BCK Capital Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • BCK Capital Management sold 259,809 NEOPHOTONICS CORP shares in Q3 2022, an estimated $4.09M.
  • BCK Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
  • BCK Capital Management's NEOPHOTONICS CORP position peaked at $4.09M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on BCK Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.